Viemed Q2 2025 Update - $VMD

4 months ago

Petty Cash

"VMD (earnings update): Home healthcare provider at $6.97, 5.1x EV/EBITDA. Q2 rev +15% YoY to $63M, EBITDA $14.3M. Ventilator patients +11.4% YoY. PAP therapy +51% YoY. Lehans acquisition adds maternal care, boosting 2024 guidance to $271-277M rev/$59-62M EBITDA. NCD finalized, favorable for VMD. Ongoing share buybacks at low valuation."

Related Stocks